Genetics testing provider 23andMe said its chief financial officer will leave the company next month after four years with the company. Steve Schoch notified 23andMe...
Today in healthcare, 23andMe buys Lemonaid Health for $400 million, and Prime and Synchrony expand healthcare financing offering. Plus, online billing makes things easier for...
Hims & Hers Health has had its biggest one-day loss in over two months, following its rival 23andMe’s agreement to buy web-based healthcare platform Lemonaid...
The busy business of home DNA facing its first major test, as consumer demand for the products is beginning to dim. The issue was surfaced by...